David, having discovered an unmet clinical Otolaryngology need with teammate Brian Shields during the 2014/15 BioInnovate fellowship program, decided to progress towards an ambitious innovative solution. Following the program, he and Brian cofounded Neurent Medical, a company developing a novel office-based treatment for Rhinitis, a condition affecting millions of people globally. As CTO, David continued to derisk the project during a 2-year period, utilising the Enterprise Ireland Commercialisation Fund and the duo recently closed a Series A round of investment of €9.3 million to progress the project towards CE and FDA approval and commercialisation.